Literature DB >> 9822165

NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats.

Y Zhang1, P A Dijkhuizen, P N Anderson, A R Lieberman, J Verhaagen.   

Abstract

Sensory axons interrupted in the dorsal roots of adult mammals are normally unable to regenerate into the spinal cord. We have investigated whether the introduction of a neurotrophin gene into the spinal cord might offer an approach to otherwise intractable spinal root injuries. The dorsal roots of the 4th, 5th, and 6th lumbar spinal nerves of adult rats were severed and reanastomosed. Fourteen to nineteen days later, adenoviral vectors containing either the LacZ or NT-3 genes were injected into the ventral horn of the lumbar spinal cord, resulting in strong expression of the transgenes in glial cells and motor neurons between 4 and 40 days after injection. When dorsal root axons were transganglionically labelled with HRP conjugated to cholera toxin subunit B, 16 to 37 days after dorsal root injury, large numbers of labelled axons could be seen to have regenerated into the cord, but only in those animals injected with vector carrying the NT-3 gene. The regenerated axons were found at the injection site, mainly in the grey matter, and had penetrated as deep as lamina V. Gene therapy with adenoviral vectors encoding a neurotrophin has therefore been shown to be capable of enhancing and directing the regeneration of a subpopulation of dorsal root axons (probably myelinated A fibres), into and through the CNS environment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822165     DOI: 10.1002/(SICI)1097-4547(19981115)54:4<554::AID-JNR12>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  17 in total

1.  Adult neuronal regeneration induced by transgenic integrin expression.

Authors:  M L Condic
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 2.  Strategies for identifying genes that play a role in spinal cord regeneration.

Authors:  M Wintzer; M Mladinic; D Lazarevic; C Casseler; A Cattaneo; J Nicholls
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

3.  Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury.

Authors:  Sara J Taylor; Ephron S Rosenzweig; John W McDonald; Shelly E Sakiyama-Elbert
Journal:  J Control Release       Date:  2006-06-22       Impact factor: 9.776

Review 4.  Sensory axon regeneration: rebuilding functional connections in the spinal cord.

Authors:  George M Smith; Anthony E Falone; Eric Frank
Journal:  Trends Neurosci       Date:  2011-11-30       Impact factor: 13.837

Review 5.  Therapeutic gene transfer to the nervous system using viral vectors.

Authors:  Joseph C Glorioso; Marina Mata; David J Fink
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

6.  Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury.

Authors:  Edmund R Hollis; Mark H Tuszynski
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord.

Authors:  M I Romero; N Rangappa; L Li; E Lightfoot; M G Garry; G M Smith
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 8.  Construction of pathways to promote axon growth within the adult central nervous system.

Authors:  George M Smith; Stephen M Onifer
Journal:  Brain Res Bull       Date:  2010-06-08       Impact factor: 4.077

9.  NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors.

Authors:  Yingpeng Liu; Lakshmi Kelamangalath; Hyukmin Kim; Seung Baek Han; Xiaoqing Tang; Jinbin Zhai; Jee W Hong; Shen Lin; Young-Jin Son; George M Smith
Journal:  Exp Neurol       Date:  2016-06-02       Impact factor: 5.330

Review 10.  Drug delivery systems for the treatment of ischemic stroke.

Authors:  Taiyoun Rhim; Dong Yun Lee; Minhyung Lee
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.